| Patent Number |
Title Of Patent |
Date Issued |
| 7172999 |
Method and preparations for stabilizing biological materials by drying methods without freezing |
February 6, 2007 |
| The present invention concerns processes for the production of dry, partially amorphous products containing biologically active and in particular therapeutically active material which are macroscopically homogeneous substance mixtures, the substance mixtures being selected from at le |
| 6689755 |
Method of stabilizing biologically active substances |
February 10, 2004 |
| The present invention relates to a rapid and readily reproducible process for stabilizing biologically active substances by combining the biologically active substance witha a stabilizingmixture and drying the resulting mixture into a dry, amorphous product by means of convection dry |
| 6676970 |
Subcutaneous osteoporosis compositions |
January 13, 2004 |
| The invention is concerned with a pharmaceutical preparation for subcutaneous, parenteral administration, which contains bisphosphonic acids or their salts as the active substance, as well as the production of this preparation. By means of the preparation in accordance with the inven |
| 6346274 |
Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and |
February 12, 2002 |
| The invention concerns parenteral pharmaceutical forms of administration containing polypeptide in the form of microparticles and a process for the production thereof. The microparticles according to the invention contain as a biodegradable polymer an ABA triblock copolymer the A block o |
| 6303113 |
Process for the production of pharmaceutical preparations containing human protein for infusion |
October 16, 2001 |
| The present invention concerns a process for the production of well-tolerated, preserved injection or infusion solutions containing human protein. |
| 6238664 |
Process for stabilizing proteins |
May 29, 2001 |
| An aqueous protein solution buffered with a potassium phosphate buffer, in which the ratio of potassium ions to sodium ions in the solution is at least 10:1, is resistant to the formation of protein aggregates and particles under conditions of freezing, thawing, lyophilization, and r |
| 6074360 |
Electromagnetic transdermal injection device and methods related thereto |
June 13, 2000 |
| Featured is a method for injection of a payload into the tissues of an organism or a body, including the steps of generating forces by electromagnetic repulsion and accelerating the payload to be injected, using the generated electromagnetic forces. The payload is thereby accelerated |
| 5919757 |
Aqueous pharmaceutical preparations of G-CSF with a long shelf life |
July 6, 1999 |
| Aqueous pharmaceutical preparations of G-CSF are disclosed that are stable on storage and a buffer selected from the group consisting of a salt of citrate, maleate, a combination of phosphate and citrate, and arginine; and at least one surfactant. |
| 5919443 |
Stable lyophilized pharmaceutical preparations of G-CSF |
July 6, 1999 |
| The present invention concerns lyophilized pharmaceutical preparations of G-CSF that contain maltose, raffinose, sucrose, trehalose or amino sugar as stabilizing agents. In additon the invention concerns a process for the production of stabilized lyophilisates as well as the use of malto |
| 5662918 |
Pharmaceutical agents containing diphosphonic acids and salts thereof |
September 2, 1997 |
| The invention concerns pharmaceutical preparations that are stable on storage, which contain at least one diphosphonic acid and/or at least one physiologically acceptable salt of such an acid as the active substance. |
| 5503827 |
Process for the production of multi-dose pharmaceutical preparations containing isolated or reco |
April 2, 1996 |
| The present invention concerns a process for the production of well-tolerated, preserved injection or infusion solutions containing human protein. |
